Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$762,837
-$173,488 QoQ
Shares Held
636
-37.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#3,374
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Eurizon SLJ Capital Ltd holds $2,552,063 across 7 Drug Manufacturers - General names. LLY ranks #1 (29.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
636 | $762,837 | |
| 2 | ABBV |
AbbVie Inc.
|
1,808 | $454,965 | |
| 3 | JNJ |
Johnson & Johnson
|
1,473 | $374,097 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,367 | $304,159 | |
| 5 | PFE |
Pfizer Inc
|
9,906 | $238,536 | |
| 6 | AMGN |
Amgen Inc
|
618 | $223,790 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,533 | $193,679 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $762,837 | 636 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $936,325 | 1,018 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $629,762 | 586 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||